Resources/
Phil Blog
Phil Blog
Translating Data into Actionable Insights to Inform your Patient Access Strategy
By Andrew Duncan, SVP of Business Operations, Pricing & Strategic Finance Pharmaceutical companies are embracing big data initiatives to drive their business objectives. For brand teams, data is valuable only when they have the right data to make informed decisions that improve access to their retail and specialty-lite therapies. Life science companies that invest in capabilities to capture, strategically analyze, and draw actionable insights from the most relevant data will realize better brand outcomes
Meet Johnny Yu, VP of Patient Experience at Phil
Next up in our Employee Spotlight series is Johnny Yu, VP of Patient Experience. Learn how Johnny’s enthusiasm, team-building skills, and drive to achieve the best patient experience make him a valuable asset at Phil. Please tell us a little bit about yourself and your role at Phil
How Drug Manufacturers Can Evolve their Provider Engagement Model to Drive Brand Performance
Evolving healthcare provider (HCP) needs and expectations have disrupted conventional customer engagement methods. The traditional reach and frequency model that had long been successful for pharma companies no longer delivers on brand goals. Several factors are driving this change
Meet Nicole Grycan, VP Commercialization at Phil
We are thrilled to have our VP of Commercialization, Nicole Grycan, share her personal journey with us in our next employee spotlight. Nicole’s industry expertise is instrumental in our mission to help people get their medications quickly, easily, and affordably. Tell me a little bit about yourself and what you do at Phil
The Evolving Role of Retail Pharmacies: What Branded Retail and Specialty-Lite Manufacturers Need to Know
Branded retail and specialty-lite pharmaceutical manufacturers must be acutely aware of the changes occurring within the retail pharmacy channel because they directly impact access and commercialization efforts. The evolving landscape – marked by the transition of retail pharmacies into primary care providers, the reduction of chain pharmacy footprints, the rise of mail order and online pharmacies, and critical labor shortages – directly influences how branded prescription medications are distributed, accessed, and managed. The following retail pharmacy trends are strong indicators that manufacturers must consider and adopt an alternative channel strategy in 2024 and beyond
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
